GlobeNewswire

Cority Announces New Growth Investment with Thoma Bravo as Majority Investor

Del

New investment from Thoma Bravo reaffirms Cority’s status as the trusted provider of environmental, health, safety and quality (EHSQ) software

Toronto, ON, May 28, 2019 (GLOBE NEWSWIRE) -- Cority, the trusted provider of environmental, health, safety and quality (EHSQ) software, has announced that it has entered into an agreement with Thoma Bravo, LLC, in which the leading private equity investment firm will own a majority stake in the company. Previous majority investor Norwest Venture Partners will continue to retain a significant stake in the business and will re-invest over half of its proceeds.

Over its 30-year history, Cority has built the only enterprise-grade, unified true SaaS platform spanning all aspects of EHSQ. Today, Cority’s award winning solutions serve over 800 clients worldwide, allowing organizations to gain actionable insights from their data, manage risk and compliance, and improve business performance by safeguarding employees, protecting the environment and streamlining complex workflows. The company has continually driven innovation on behalf of its clients, most recently with the introduction of its Quality and Predictive Analytics solutions and announced record levels of growth and investment in 2018.

As organizations increasingly recognize the value and strategic importance of improved EHSQ outcomes, the need for a comprehensive, holistic EHSQ platform has risen in tandem. Cority, which enjoys the industry’s best client satisfaction and retention rates and supports millions of end users, is well positioned to address these needs and lead a $4bn+ industry.

“Our longstanding core values of integrity, quality, customer centricity, community, and diversity continue to underpin our success,” said Cority CEO Mark Wallace.  “We are excited to move to a new phase of our success story by welcoming Thoma Bravo to Cority and look forward to sharing the benefits of their software expertise and investment capital with our clients, partners, and employees.”

“We have tracked Cority’s success for years through our numerous investments in other segments of the broader Governance Risk and Compliance (GRC) market,” said Hudson Smith, a Partner at Thoma Bravo. “With so many point solutions in the GRC market, we believe that Cority is unique in that it offers enterprise clients a single platform to manage their health, safety, environmental, sustainability, operational risk and quality needs. We look forward to helping Mark and the team further invest to deepen and broaden Cority’s solutions.”

Rob Arditi, General Partner of existing investor Norwest, noted, “It has been a great journey with Cority over the last few years partnering with management to expand product capabilities, elevate the company’s brand and fully cement Cority’s position as the global EHSQ leader.  We’re excited to continue our partnership with Cority alongside Thoma Bravo.”

Georgian Partners will also re-invest a portion of its existing investment in the business, and continue to advise the company in the area of applied analytics.

The transaction is expected to close by the end of June 2019 subject to customary closing conditions.

Cority is being advised on the transaction by Harris Williams & Co. and Goodwin Proctor LLP, and co-advised by William Blair & Co. Thoma Bravo is being advised by Kirkland & Ellis LLP.

###

About Cority

Cority is the most trusted environmental, health, safety, and quality (EHSQ) software for assuring client success. Cority enables organizations to utilize EHSQ software to advance their journey to sustainability and operational excellence by combining the deepest domain expertise with the most comprehensive and secure true SaaS platform. With 30+ years of innovation and experience, Cority’s team of over 350 experts serve over 800 clients in 100 countries, supporting 2.5 million end users. The company enjoys the industry’s highest levels of client satisfaction and has received many awards for its strong employee culture and outstanding business performance.

About Thoma Bravo, LLC

Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. With a series of funds representing more than $30 billion in capital commitments, Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make accretive acquisitions intended to accelerate revenue and earnings, with the goal of increasing the value of the business. Representative past and present portfolio companies include industry leaders such as ABC Financial, Blue Coat Systems, Deltek, Digital Insight, Frontline Education, Global Healthcare Exchange, Hyland Software, Imprivata, iPipeline, PowerPlan, Qlik, Riskonnect, PEC, SailPoint, SolarWinds, Sparta Systems, TravelClick and Veracode. The firm has offices in San Francisco and Chicago. For more information, visit thomabravo.com.

Attachment

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Camunda Announces Extensive Speaker Lineup for CamundaCon 201924.6.2019 09:00:00 CESTPressemelding

Early Bird Tickets for the annual Camunda Community event available until June 30 BERLIN, June 24, 2019 (GLOBE NEWSWIRE) -- Camunda, an open source software company reinventing workflow automation, today announced the speaker lineup for its annual user conference – CamundaCon – featuring presenters from LinkedIn, Roche and AXA, among others. Demand for the tech-focused event is significantly outpacing last year and discounted Early Bird tickets are available only until June 30. CamundaCon, an event created for software developers, enterprise architects and IT executives who want to learn about workflow and decision automation, takes place September 12-13 in the heart of Berlin. It brings together workflow automation and BPMN experts, the global Camunda community and the Camunda engineering team to share best practices, discuss the product roadmap and get inspiration from fellow Camunda users. New this year to the annual conference is a developer-focussed track, with dedicated tutorials

ERYTECH Announces Opening of Operations at its New Princeton, NJ GMP Manufacturing Facility24.6.2019 07:30:00 CESTPressemelding

Inauguration event held last week to officially open 30,000 sq. ft GMP manufacturing facility constructed in Princeton, NJ to produce lead product candidate eryaspase in the United States PRINCETON, N.J. and CAMBRIDGE, Mass. and LYON, France, June 24, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, announced today the opening of its new Princeton, NJ GMP manufacturing facility. The facility will support production capacity needs for eryaspase, the Company’s lead product candidate for patients in the United States. Eryaspase is in Phase 3 clinical development for the treatment of second-line pancreatic cancer. The Phase 3 clinical trial, which is referred to as the Trybeca-1 trial is expected to enroll approximately 500 patients with second-line metastatic pancreatic cancer at approximately 120 clinical sites in Europe and the Unite

Minerva Neurosciences to Host Live Conference Call and Webcast With Key Opinion Leaders to Discuss Successful Insomnia Trial With Seltorexant23.6.2019 23:30:00 CESTPressemelding

Call scheduled for 8:30 a.m. Eastern Time on June 24 to review results of successful Phase 2b trial showing achievement of primary and secondary endpoints with potential first-in-class specific orexin-2 receptor antagonist for the treatment of insomnia Key Opinion Leaders, Dr. Thomas Roth and Dr. David Kupfer, to be joined by Dr. Remy Luthringer, Executive Chairman and CEO of Minerva WALTHAM, Mass., June 23, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, will host a live conference call and webcast tomorrow, June 24, 2019 to discuss the results of its successful Phase 2b clinical trial of seltorexant (MIN-202) in patients with insomnia disorder (see dial-in information below). The Company plans to issue a press release detailing top-line results prior to the call. Conference Call Information: Minerva Neurosciences will hold a conferen

GE Board of Directors Authorizes Regular Quarterly Dividend21.6.2019 19:35:00 CESTPressemelding

BOSTON, June 21, 2019 (GLOBE NEWSWIRE) -- The Board of Directors of GE (NYSE: GE) today declared a $0.01 per share dividend on the outstanding common stock of the Company. The dividend is payable July 25, 2019 to shareowners of record at the close of business on July 1, 2019. The ex-dividend date is June 28, 2019. About GE GE (NYSE:GE) drives the world forward by tackling its biggest challenges. By combining world-class engineering with software and analytics, GE helps the world work more efficiently, reliably, and safely. For more than 125 years, GE has invented the future of industry, and today it leads new paradigms in additive manufacturing, materials science, and data analytics. GE people are global, diverse and dedicated, operating with the highest integrity and passion to fulfill GE's mission and deliver for our customers. www.ge.com GE's Investor Relations website at www.ge.com/investor and our corporate blog at www.ge.com/reports and @GE_Reports on Twitter, as well as GE's Fac

Wildflower Featured in NetworkNewsWire Publication Summarizing Amazing Profits Found in Cannabis21.6.2019 14:30:00 CESTPressemelding

NEW YORK, June 21, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities. To view the full publication, titled “Searching for the Next Super Nova,” visit: http://nnw.fm/P7LFo. Quarter-over-quarter sales growth is one of the indicators used to target explosive upside potential. Similar growth patterns were exhibited by many of the cannabis behemoths prior to parabolic price increases. In what may be an equally telling indicator, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) revenues have now increased 11 consecutive quarters, quarter on quarter, ever since the company started selling its hemp-based CBD products. Founded in 2012 as a private company, Wildflower Brands went public in 2014 and has been on a tear ever since. Wildflower is an integrated health-and-wellness company crea

Fortuna Reports Results of Annual General Meeting21.6.2019 11:00:00 CESTPressemelding

VANCOUVER, British Columbia, June 21, 2019 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) hereby announces the voting results at the Company’s annual general meeting held on June 20, 2019. A total of 106,646,841 common shares were represented at the meeting, being 66.58% of the Company’s issued and outstanding shares as at the record date. Shareholders voted in favour of all matters brought before the meeting including the appointment of auditors, and the election of management’s nominees as directors. Detailed results of the votes on the election of directors are as follows: Director Votes For Votes Withheld Jorge Ganoza Durant Simon Ridgway Mario Szotlender David Farrell David Laing Alfredo Sillau Kylie Dickson 68,615,628 (98.9%) 39,765,591 (57.3%) 67,659,125 (97.5%) 66,958,952 (96.5%) 68,280,736 (98.4%) 68,434,565 (98.7%) 68,393,226 (98.6%) 755,610 (1.1%) 29,605,647 (42.7%) 1,712,113 (2.5%) 2,412,286 (3.5%) 1,090,502 (1.6%) 936,673 (1.3%) 978,012 (1.4%) About F